Open AccessComment on: Incidence of Adverse Psychiatric Events During the Treatment of Inflammatory Bowel Disease With Biologic Therapies: A Systematic Review
Author(s) -
Jessica K. SalwenDeremer,
Brittany C. Speed
Publication year - 2019
Publication title -
crohn s and colitis 360
Language(s) - English
Resource type - Journals
ISSN - 2631-827X
DOI - 10.1093/crocol/otz051
Subject(s) - inflammatory bowel disease , depression (economics) , anxiety , adverse effect , medicine , disease , incidence (geometry) , psychiatry , systematic review , intensive care medicine , medline , law , macroeconomics , physics , optics , political science , economics
Lay Summary In this article, we comment on work by Jain and colleagues. They found that there are very few instances of increased anxiety and depression in drug trials for IBD. We believe these rates are likely higher and discuss supporting literature.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom